hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness
- PMID: 25151968
- DOI: 10.1038/onc.2014.270
hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness
Abstract
Stress hormones have been implicated in both tumor initiation and progression. Human telomerase reverse transcriptase (hTERT) is overexpressed in cancer cells and associated with malignant tumor progression and poor outcome. We thus sought to determine whether the stress hormone norepinephrine (NE) could induce hTERT expression and subsequently ovarian cancer progression. Unexpectedly, NE induced hTERT transcript and protein expression, and subsequently ovarian cancer cell invasion. Pharmacologic inhibition of β2-adrenergic receptor 2 and protein kinase A, as well as silencing of hypoxia-inducible factor-1α and c-Myc expression, profoundly attenuated NE-induced hTERT expression. Strikingly, stimulation of the cells with NE or ectopic expression of hTERT induced expression of Slug, ovarian cancer cell epithelial-mesenchymal transition (EMT) and invasion. Silencing of hTERT expression abrogated NE-induced ovarian cancer cell invasion, EMT and Slug expression. In addition, silencing of Slug expression significantly inhibited NE- and hTERT-induced ovarian cancer cell EMT and invasion. Moreover, continuous exposure to NE was sufficient to enhance in vivo hTERT expression and metastasis of ovarian cancer cells to the lung. Finally, we provide evidence that hTERT links Src to Slug expression in NE-induced ovarian cancer EMT and metastasis. We thus demonstrate a novel role of hTERT in stress hormone-induced ovarian cancer aggressiveness through inducing Slug, providing novel biomarkers and potential therapeutic targets for ovarian cancer.
Similar articles
-
Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.J Vis Exp. 2023 May 26;(195). doi: 10.3791/6561. J Vis Exp. 2023. PMID: 37235796
-
Resveratrol attenuates norepinephrine-induced ovarian cancer invasiveness through downregulating hTERT expression.Arch Pharm Res. 2016 Feb;39(2):240-248. doi: 10.1007/s12272-015-0666-8. Epub 2015 Oct 1. Arch Pharm Res. 2016. PMID: 26428673
-
UBE2J1 is identified as a novel plasma cell-related gene involved in the prognosis of high-grade serous ovarian cancer.J Transl Med. 2025 Jan 28;23(1):129. doi: 10.1186/s12967-025-06135-9. J Transl Med. 2025. PMID: 39876019 Free PMC article.
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article. Review.
-
The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness.Biochim Biophys Acta. 2012 Dec;1826(2):272-96. doi: 10.1016/j.bbcan.2012.04.008. Epub 2012 May 10. Biochim Biophys Acta. 2012. PMID: 22579961 Free PMC article. Review.
Cited by
-
Cost-Effective Trap qPCR Approach to Evaluate Telomerase Activity: an Important Tool for Aging, Cancer, and Chronic Disease Research.Clinics (Sao Paulo). 2021 Feb 5;76:e2432. doi: 10.6061/clinics/2021/e2432. eCollection 2021. Clinics (Sao Paulo). 2021. PMID: 33567048 Free PMC article.
-
Multiple types of distress are prospectively associated with increased risk of ovarian cancer.Cancer Med. 2023 Jul;12(14):15404-15413. doi: 10.1002/cam4.6125. Epub 2023 Jun 16. Cancer Med. 2023. PMID: 37326414 Free PMC article.
-
Human telomerase reverse transcriptase (hTERT) promotes gastric cancer invasion through cooperating with c-Myc to upregulate heparanase expression.Oncotarget. 2016 Mar 8;7(10):11364-79. doi: 10.18632/oncotarget.6575. Oncotarget. 2016. PMID: 26689987 Free PMC article.
-
Resveratrol suppresses breast cancer cell invasion by inactivating a RhoA/YAP signaling axis.Exp Mol Med. 2017 Feb 24;49(2):e296. doi: 10.1038/emm.2016.151. Exp Mol Med. 2017. PMID: 28232662 Free PMC article.
-
RBFOX3 Promotes Gastric Cancer Growth and Progression by Activating HTERT Signaling.Front Oncol. 2020 Jul 20;10:1044. doi: 10.3389/fonc.2020.01044. eCollection 2020. Front Oncol. 2020. Retraction in: Front Oncol. 2021 Aug 31;11:738970. doi: 10.3389/fonc.2021.738970. PMID: 32903312 Free PMC article. Retracted.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous